Archive: 30/03/2018

A hiccup in gene therapy progress?

Zebrafish, roundworms, fruit flies, mice, rats, rabbits, dogs, cats, pigs, and monkeys provide steppingstones to clinical trials to evaluate new treatments for people. The value of animal studies continues, even after a new ...

Mar 30, 2018

0

14

Alternative, non-opioid treatments for chronic pain

An estimated 2 million people in the U.S. are addicted to prescription opioids—powerful doctor-prescribed medications for chronic or severe pain. The drugs are commonly prescribed to treat gastrointestinal pain caused by ...

Mar 30, 2018

Lower thromboembolic risk with new A-fib after CABG versus NVAF

(HealthDay)—For patients post coronary artery bypass graft (CABG) surgery, new-onset postoperative atrial fibrillation (POAF) is associated with lower long-term thromboembolic risk than that seen among patients with nonvalvular ...

Mar 30, 2018

0

3

New facial expression app to monitor mood in stroke patients

A new medical app that helps brain-damaged stroke patients communicate how they are feeling has been developed and tested by researchers at the University of Nottingham.

Mar 30, 2018

0

3

Drug makers engage in 'co-opetition' through drug middlemen

Prescription drug consumers confounded by the cost of their medications can get a peek behind the curtain thanks to new Washington University in St. Louis research into the complex "co-opetition"—cooperation and competition—among ...

Mar 30, 2018

Islet transplantation improves quality of life in T1DM

(HealthDay)—There are significant improvements in health-related quality of life (HRQOL) following islet transplantation in patients with type 1 diabetes complicated by severe hypoglycemia, according to a study published ...

Mar 30, 2018

0

1

Pharmacists have responsibility to check opioid Rx are legitimate

(HealthDay)—Pharmacists should be aware that they are expected to take steps to make sure opioid prescriptions are written for legitimate medical purposes, and should document these efforts, according to a report published ...

Mar 30, 2018

0

1

Blincyto approval expanded for specific leukemia

(HealthDay)—The U.S. Food and Drug Administration says it has expanded approval for Blincyto (blinatumomab) to include adults and children with B-cell precursor acute lymphoblastic leukemia who are in remission but who ...

Mar 30, 2018